March 20, 2024, 11:12 a.m. | SC Staff

SC Magazine feed for Risk Management www.scmagazine.com

U.S. endocrine-focused pharmaceutical development and commercialization firm Crinetics Pharmaceuticals has confirmed an ongoing investigation into a cybersecurity incident claimed by the LockBit ransomware operation.

cyberattack cybersecurity cybersecurity incident development incident investigation lockbit lockbit ransomware pharmaceutical pharmaceuticals ransomware under

SOC 2 Manager, Audit and Certification

@ Deloitte | US and CA Multiple Locations

Lead Technical Product Manager - Threat Protection

@ Mastercard | Remote - United Kingdom

Data Privacy Officer

@ Banco Popular | San Juan, PR

GRC Security Program Manager

@ Meta | Bellevue, WA | Menlo Park, CA | Washington, DC | New York City

Cyber Security Engineer

@ ASSYSTEM | Warrington, United Kingdom

Privacy Engineer, Technical Audit

@ Meta | Menlo Park, CA